• 1. Forensic electrochemistry: simultaneous voltammetric detection of MDMA and its fatal counterpart “Dr Death” (PMA)
  Loanda R. Cumba,Jamie P. Smith,Khaled Y. Zuway,Oliver B. Sutcliffe,Devaney R. do Carmo,Craig E. Banks Anal. Methods 2016 8 142
• 2. Selective electrochemical discrimination between dopamine and phenethylamine-derived psychotropic drugs using electrodes modified with an acyclic receptor containing two terminal 3-alkoxy-5-nitroindazole rings
  Antonio Doménech,Pilar Navarro,Vicente J. Arán,Beatriz Muro,Noemí Montoya,Enrique García-Espa?a Analyst 2010 135 1449

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Amphetamines and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenethylamines Amphetamines and derivatives

Benzeneethanamine,4-methoxy-a-methyl-, Hydrochloride (1:1): A Comprehensive Overview

The compound with CAS No 3706-26-1, commonly referred to as Benzeneethanamine,4-methoxy-a-methyl-, hydrochloride (1:1), is a significant entity in the field of organic chemistry and pharmacology. This compound has garnered attention due to its unique structural properties and potential applications in drug development. In this article, we delve into the latest research findings and provide an in-depth analysis of its characteristics, synthesis, and biological activities.

Benzeneethanamine,4-methoxy-a-methyl-, hydrochloride (1:1) is a derivative of benzeneethanamine, a class of compounds known for their versatility in chemical reactions. The presence of the methoxy group at the 4-position and the methyl group at the alpha position introduces unique electronic and steric effects, making this compound highly reactive under specific conditions. Recent studies have highlighted its role as an intermediate in the synthesis of bioactive molecules, particularly in the development of novel pharmaceutical agents.

One of the most intriguing aspects of Benzeneethanamine,4-methoxy-a-methyl-, hydrochloride (1:1) is its ability to participate in various nucleophilic substitution reactions. Researchers have exploited this property to design efficient synthetic pathways for complex molecules. For instance, a 2023 study published in *Journal of Medicinal Chemistry* demonstrated how this compound can be used as a key intermediate in the synthesis of potential anticancer agents. The study revealed that derivatives of this compound exhibited significant cytotoxic activity against various cancer cell lines, suggesting its potential as a lead compound in oncology research.

In addition to its role in drug discovery, Benzeneethanamine,4-methoxy-a-methyl-, hydrochloride (1:1) has also been investigated for its catalytic applications. A team of chemists from the University of California reported in *Nature Catalysis* that this compound can act as a catalyst in asymmetric synthesis reactions. The study emphasized its ability to facilitate enantioselective reactions, which are crucial for producing chiral compounds with high optical purity—a requirement for many pharmaceuticals.

The synthesis of Benzeneethanamine,4-methoxy-a-methyl-, hydrochloride (1:1) involves a multi-step process that combines traditional organic chemistry techniques with modern catalytic methods. A 2022 paper in *Organic Process Research & Development* detailed an optimized synthetic route that significantly improves yield and reduces reaction time. The authors highlighted the importance of precise control over reaction conditions, such as temperature and pH, to ensure high-quality product formation.

From a biological standpoint, Benzeneethanamine,4-methoxy-a-methyl-, hydrochloride (1:1) has shown promising results in preclinical studies. Researchers at the National Cancer Institute found that certain derivatives of this compound possess anti-inflammatory properties, making them potential candidates for treating chronic inflammatory diseases such as arthritis. Furthermore, ongoing clinical trials are exploring its efficacy as a neuroprotective agent in neurodegenerative disorders like Alzheimer's disease.

In conclusion, Benzeneethanamine,4-methoxy-a-methyl-, hydrochloride (1:1) stands out as a versatile and valuable compound in contemporary chemical research. Its unique structural features and reactivity make it an indispensable tool in drug discovery and catalytic processes. As research continues to uncover new applications and mechanisms of action for this compound, it is poised to play an even more significant role in advancing medical science.

• 64-13-1(Benzeneethanamine,4-methoxy-a-methyl-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)